Table 3.

The distribution of HLA-DRB1*0901, 1501 and DQB1*0301, 0602 in patients and control group

HLA	ECC	HPV16ECC	Control	ECC			HPV16ECC
	(n = 200)	(n = 30)	(n = 150)	P	OR	95 % CI	P	OR	95 % CI
DRB1*0901	21	11	14	0.857	1.14	0.559–2.323	0.461	1.505	0.650–3.487
DRB1*1501	91	42	38	0.000	2.46	1.551–3.903	0.000	3.095	1.753–5.463
DQB1*0301	152	57	73	0.000	3.34	2.117–5.269	0.004	2.410	1.362–4.248
DQB1*0602	138	58	84	0.017	1.75	1.126–2.716	0.039	1.899	1.069–3.373